Physician profile
Eunice Yang
NPI 1114221942
$31,181.93
in general payments reported to CMS, 2019-2025
10 companies · $2,130 in 2025
The $2,130 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $7,122 · 2021: $13K · 2022: $4,888 · 2023: $2,770 · 2024: $1,216 · 2025: $2,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,666 · Travel and Lodging: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,665.95 |
| Travel and Lodging | $2,450.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,837.26 | 2019-2025 | Ensite Precision, Aveir, Ensite |
| Boston Scientific Corporation | $10,702.32 | 2020-2024 | Watchman Access System, Latitude Communicator Power Supply |
| Medtronic, INC. | $3,722.78 | 2021-2025 | Selectsecure, Affera Mapping System, Micra |
| Medtronic Vascular, INC. | $1,451.84 | 2020 | |
| Medical Device Business Services, INC. | $1,198.86 | 2022 | |
| Biosense Webster, INC. | $748.17 | 2021-2025 | Carto 3 |
| Biotronik INC. | $286.45 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.66 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $52.24 | 2023-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $27.35 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunice Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.